232 related articles for article (PubMed ID: 1438187)
1. Crystallization, sequence, and preliminary crystallographic data for an antipeptide Fab 50.1 and peptide complexes with the principal neutralizing determinant of HIV-1 gp120.
Stura EA; Stanfield RL; Fieser GG; Silver S; Roguska M; Hincapie LM; Simmerman HK; Profy AT; Wilson IA
Proteins; 1992 Dec; 14(4):499-508. PubMed ID: 1438187
[TBL] [Abstract][Full Text] [Related]
2. Conformation of the principal neutralizing determinant of human immunodeficiency virus type 1 in complex with an anti-gp120 virus neutralizing antibody studied by two-dimensional nuclear magnetic resonance difference spectroscopy.
Zvi A; Feigelson DJ; Hayek Y; Anglister J
Biochemistry; 1997 Jul; 36(28):8619-27. PubMed ID: 9214308
[TBL] [Abstract][Full Text] [Related]
3. Expression, purification, and isotope labeling of a gp120 V3 peptide and production of a Fab from a HIV-1 neutralizing antibody for NMR studies.
Sharon M; Görlach M; Levy R; Hayek Y; Anglister J
Protein Expr Purif; 2002 Apr; 24(3):374-83. PubMed ID: 11922753
[TBL] [Abstract][Full Text] [Related]
4. A monoclonal antibody Fab fragment crystallized with and without a peptide epitope from HIV.
Pfeffer-Hennig S; Wessner H; Hennig M; Dauter Z; Hausdorf G; Höhne WE
Proteins; 1993 Aug; 16(4):437-9. PubMed ID: 7689218
[TBL] [Abstract][Full Text] [Related]
5. Structure-based design of a constrained peptide mimic of the HIV-1 V3 loop neutralization site.
Ghiara JB; Ferguson DC; Satterthwait AC; Dyson HJ; Wilson IA
J Mol Biol; 1997 Feb; 266(1):31-9. PubMed ID: 9054968
[TBL] [Abstract][Full Text] [Related]
6. Antibody domain exchange is an immunological solution to carbohydrate cluster recognition.
Calarese DA; Scanlan CN; Zwick MB; Deechongkit S; Mimura Y; Kunert R; Zhu P; Wormald MR; Stanfield RL; Roux KH; Kelly JW; Rudd PM; Dwek RA; Katinger H; Burton DR; Wilson IA
Science; 2003 Jun; 300(5628):2065-71. PubMed ID: 12829775
[TBL] [Abstract][Full Text] [Related]
7. Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1.
Borbe HC; Stuber G; Wagner R; Wolf H; Modrow S
J Pept Sci; 1995; 1(2):109-23. PubMed ID: 9222988
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of a peptide complex of anti-influenza peptide antibody Fab 26/9. Comparison of two different antibodies bound to the same peptide antigen.
Churchill ME; Stura EA; Pinilla C; Appel JR; Houghten RA; Kono DH; Balderas RS; Fieser GG; Schulze-Gahmen U; Wilson IA
J Mol Biol; 1994 Aug; 241(4):534-56. PubMed ID: 7520084
[TBL] [Abstract][Full Text] [Related]
9. Crystallization and preliminary X-ray diffraction studies of a monoclonal antibody Fab fragment against foot-and-mouth disease virus and of its complex with the main antigenic site peptide.
Verdaguer N; Mateu MG; Bravo J; Tormo J; Giralt E; Andreu D; Domingo E; Fita I
Proteins; 1994 Feb; 18(2):201-3. PubMed ID: 8159669
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of the broadly cross-reactive HIV-1-neutralizing Fab X5 and fine mapping of its epitope.
Darbha R; Phogat S; Labrijn AF; Shu Y; Gu Y; Andrykovitch M; Zhang MY; Pantophlet R; Martin L; Vita C; Burton DR; Dimitrov DS; Ji X
Biochemistry; 2004 Feb; 43(6):1410-7. PubMed ID: 14769016
[TBL] [Abstract][Full Text] [Related]
11. Preliminary crystallographic analysis of the Fab fragment of an antibody against HIV gp120.
Vyas MN; Vyas NK; Liou RS; Chang TW; Quiocho FA
J Mol Biol; 1990 Jul; 214(1):23-4. PubMed ID: 1695249
[TBL] [Abstract][Full Text] [Related]
12. Preliminary crystallographic analysis of a Fab specific for P-glycoprotein with and without bound peptide.
Vasudevan S; Johns KL; Rose DR
J Mol Biol; 1994 Sep; 241(5):736-8. PubMed ID: 7915332
[TBL] [Abstract][Full Text] [Related]
13. Use of streptococcal protein G in obtaining crystals of an antibody Fab fragment in complex with a meningococcal antigen.
Derrick JP; Feavers I; Maiden MC
Acta Crystallogr D Biol Crystallogr; 1999 Jan; 55(Pt 1):314-6. PubMed ID: 10089436
[TBL] [Abstract][Full Text] [Related]
14. Structural mimicry and enhanced immunogenicity of peptide epitopes displayed on filamentous bacteriophage. The V3 loop of HIV-1 gp120.
di Marzo Veronese F; Willis AE; Boyer-Thompson C; Appella E; Perham RN
J Mol Biol; 1994 Oct; 243(2):167-72. PubMed ID: 7523682
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of the principal neutralization site of HIV-1.
Ghiara JB; Stura EA; Stanfield RL; Profy AT; Wilson IA
Science; 1994 Apr; 264(5155):82-5. PubMed ID: 7511253
[TBL] [Abstract][Full Text] [Related]
16. Structure determination of an Fab fragment that neutralizes human rhinovirus 14 and analysis of the Fab-virus complex.
Liu H; Smith TJ; Lee WM; Mosser AG; Rueckert RR; Olson NH; Cheng RH; Baker TS
J Mol Biol; 1994 Jul; 240(2):127-37. PubMed ID: 8027997
[TBL] [Abstract][Full Text] [Related]
17. Structural rationale for the broad neutralization of HIV-1 by human monoclonal antibody 447-52D.
Stanfield RL; Gorny MK; Williams C; Zolla-Pazner S; Wilson IA
Structure; 2004 Feb; 12(2):193-204. PubMed ID: 14962380
[TBL] [Abstract][Full Text] [Related]
18. Preliminary crystallographic studies of an anti-HIV-1 protease antibody that inhibits enzyme activity.
Lescar J; Stouracova R; Riottot MM; Chitarra V; Brynda J; Fabry M; Horejsi M; Sedlacek J; Bentley GA
Protein Sci; 1996 May; 5(5):966-8. PubMed ID: 8732768
[TBL] [Abstract][Full Text] [Related]
19. Crystal parameters and molecular replacement of an anticholera toxin peptide complex.
Shoham M; Proctor P; Hughes D; Baldwin ET
Proteins; 1991; 11(3):218-22. PubMed ID: 1749774
[TBL] [Abstract][Full Text] [Related]
20. Construction of an HIV-1 peptide vaccine containing a multideterminant helper peptide linked to a V3 loop peptide 18 inducing strong neutralizing antibody responses in mice of multiple MHC haplotypes after two immunizations.
Ahlers JD; Pendleton CD; Dunlop N; Minassian A; Nara PL; Berzofsky JA
J Immunol; 1993 Jun; 150(12):5647-65. PubMed ID: 8515081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
